Akari Therapeutics' Nomacopan Is A Potential Blockbuster
November 09, 2023 at 09:50 AM EST
Nomacopan, a complement inhibitor with dual working, is a potential blockbuster with widespread use and already an established safety profile.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|